JARID2抑制重新编程人类造血细胞原始细胞以增强骨髓移植
Wentao Han1, Hassan Bjeije1, Hamza Celik1
1Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA, 63110.
bioRxiv : the preprint server for biology
|September 15, 2025
概括
抑制JARID2可以增强来自带血的人类造血干细胞和前代细胞 (HSPC) 的数量和功能. 这种新的方法扩展了功能性HSPCs ex vivo,改善了干细胞移植的准入.
科学领域:
- 血液学 血液学 血液学
- 干细胞生物学 干细胞生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 造血干细胞移植 (HSCT) 对于治疗血液疾病至关重要.
- 带血 (UCB) 是血造干细胞和HSCT的祖先细胞 (HSPC) 的重要来源.
- 在UCB有限的HSPC数量限制了其临床应用.
研究的目的:
- 调查抑制JARID2以增强人类HSPC功能的潜力.
- 探索JARID2抑制对HSPC的影响背后的机制.
主要方法:
- 在人类UCB衍生的HSPC中利用JARID2的构成性和过渡性淘汰.
- 进行了体外和体内功能测试,以评估HSPC扩张和自我更新.
- 分析基因表达模式,包括STAT1和MHCII类免疫类型.
主要成果:
- JARID2 knockdown显著增加了人类HSPCs的数量和功能.
- 观察到的表型独立于PRC2辅因子活性,使其与EZH2抑制区别开来.
- 抑制JARID2诱导了一个静止的,自我更新的基因表达程序,涉及STAT1上调和MHCII类免疫类型.
结论:
- 抑制JARID2是一种新的,可逆的策略,用于扩大功能性UCB衍生的HSPCsex vivo.
- 这种方法有可能改善患者获得拯救生命的干细胞移植的机会.
- 这些发现表明JARID2作为增强干细胞疗法的治疗点.
相关概念视频
01:01Regulation of Hematopoietic Stem Cells
4.0K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.0K
01:19Multipotency of Hematopoietic Stem Cells
3.8K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.8K
01:22Bone Marrow Sampling and Transplants
899
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
899
01:21Stem Cell Therapy for Tissue Regeneration
4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K
01:15Differentiation of Common Myeloid Progenitor Cells
3.9K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.9K
01:21Hematopoiesis
8.7K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
8.7K